Education
About Us
Working with TipRanks
Follow Us
Ainos (AIMD)
NASDAQ:AIMD
AIMD Stock Chart & Stats
$1.79
-$0.12(-17.67%)
At close: 4:00 PM EST
$1.79
-$0.12(-17.67%)
Day’s Range― - ―
52-Week Range$1.61 - $4.75
Previous CloseN/A
Volume220.33K
Average Volume (3M)78.00K
Market Cap
$13.38M
Enterprise Value$21.44M
Total Cash (Recent Filing)$1.13M
Total Debt (Recent Filing)$11.00M
Price to Earnings (P/E)―
Beta1.72
Next Earnings
Mar 06, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.64
Shares Outstanding6,982,675
10 Day Avg. Volume93,591
30 Day Avg. Volume77,998
Financial Highlights & Ratios
PEG Ratio0.03
Price to Book (P/B)1.40
Price to Sales (P/S)1045.31
P/FCF Ratio-3.72
Enterprise Value/Market Cap1.60
Enterprise Value/Revenue189.69
Enterprise Value/Gross Profit229.41
Enterprise Value/Ebitda-2.26
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Ainos News
AIMD FAQ
What was Ainos’s price range in the past 12 months?
Ainos lowest stock price was $1.61 and its highest was $4.75 in the past 12 months.
What is Ainos’s market cap?
Ainos’s market cap is $13.38M.
When is Ainos’s upcoming earnings report date?
Ainos’s upcoming earnings report date is Mar 06, 2026 which is in 49 days.
How were Ainos’s earnings last quarter?
Ainos released its earnings results on Nov 13, 2025. The company reported -$0.644 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.644.
Is Ainos overvalued?
According to Wall Street analysts Ainos’s price is currently Overvalued.
Does Ainos pay dividends?
Ainos does not currently pay dividends.
What is Ainos’s EPS estimate?
Ainos’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Ainos have?
Ainos has 6,982,675 shares outstanding.
What happened to Ainos’s price movement after its last earnings report?
Ainos reported an EPS of -$0.644 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -14.341%.
Which hedge fund is a major shareholder of Ainos?
Currently, no hedge funds are holding shares in AIMD
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Ainos
Ainos, Inc., a healthcare company, engages in the developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan. The company was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. Ainos, Inc. was incorporated in 1984 and is based in San Diego, California.
Technical Analysis
Bioline RX Ltd Sponsored ADR
―
Soligenix
―
Chemomab Therapeutics
―
Abpro Holdings
―
FibroBiologics, Inc.
―